This study reveals a complex immune microenvironment in chordoma, characterized by elevated immune checkpoint expression (e.g., PD-1, CTLA-4), a highly immunogenic subtype (Cluster 1), and a T cell-centric regulatory network with CCR7 as a key modulator. The gene discussed is CCR7; the disease is chordoma.